Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $886.53 billion, total revenue of $172.71 billion and a weighted average PE ratio of 49.01.
Market Cap
886.53B
Revenue
172.71B
Profits
18.09B
PE Ratio
49.01
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 242.77B | -2.98% | 2,748,336 | 46.34B |
| 2 | DHR | Danaher Corporation | 151.57B | -2.53% | 3,636,477 | 25.11B |
| 3 | NTRA | Natera, Inc. | 57.75B | -5.87% | 2,500,021 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 47.74B | -1.00% | 1,869,462 | 7.37B |
| 5 | WAT | Waters Corporation | 42.88B | -0.84% | 1,074,982 | 4.64B |
| 6 | IQV | IQVIA Holdings Inc. | 42.79B | -2.30% | 1,105,081 | 16.98B |
| 7 | ILMN | Illumina, Inc. | 41.30B | -6.86% | 4,381,650 | 4.49B |
| 8 | IDXX | IDEXX Laboratories, Inc. | 40.60B | -2.21% | 502,361 | 4.55B |
| 9 | MTD | Mettler-Toledo International Inc. | 30.72B | -0.56% | 196,049 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 25.28B | 0.99% | 986,852 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 25.21B | -1.28% | 1,782,386 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 22.91B | -8.83% | 3,387,285 | 1.18B |
| 13 | RVTY | Revvity, Inc. | 17.11B | -2.58% | 2,678,775 | 2.91B |
| 14 | MEDP | Medpace Holdings, Inc. | 16.83B | -2.84% | 219,122 | 2.78B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.56B | -1.87% | 1,923,177 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.48B | -3.92% | 984,006 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.44B | -0.31% | 2,902,073 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.13B | -10.90% | 2,044,272 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.53B | -0.41% | 291,657 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.21B | -1.62% | 1,654,153 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.72B | -8.36% | 1,117,652 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.29B | -9.85% | 2,533,748 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.59B | -6.34% | 1,732,103 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.30B | -8.68% | 2,568,440 | 458.09M |
| 25 | WGS | GeneDx Holdings Corp. | 2.13B | -6.23% | 816,895 | 454.43M |
| 26 | NEO | NeoGenomics, Inc. | 2.12B | -13.72% | 5,099,716 | 766.30M |
| 27 | FRNM | Freenome, Inc. | 1.76B | -2.79% | 712,304 | 35.41M |
| 28 | PSNL | Personalis, Inc. | 1.71B | -2.26% | 5,659,788 | 69.67M |
| 29 | OPK | OPKO Health, Inc. | 1.09B | -7.01% | 2,455,416 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.02B | -8.98% | 609,146 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 566.26M | -8.33% | 368,607 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 409.38M | -6.55% | 1,801,504 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 295.01M | -3.79% | 102,160 | 102.94M |
| 34 | XGN | Exagen Inc. | 198.41M | -3.19% | 272,065 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 169.90M | 6.16% | 32,043 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 110.61M | -7.90% | 460,087 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 108.45M | -4.44% | 247,307 | 537.08K |
| 38 | MDXH | MDxHealth SA | 57.24M | 0.50% | 184,490 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 41.98M | -2.29% | 18,162 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.54M | 0.63% | 15,406 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 9.06M | -4.28% | 14,820 | - |
| 42 | XWEL | XWELL, Inc. | 6.88M | -2.15% | 28,030 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.27M | -2.10% | 259,163 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.69M | 1.90% | 103,101 | 466.30K |